β0ToxinA®- New hope to patients with post-stroke spasticity

Newsletter - November 2007

Stroke is the most important cause of neurological disabilities in adults. According to the American Heart Association and the Clinical Rehabilitation journal, between 19 and 38 % of stroke survivors are affected by disabling spasticity.

Leggi tutto...

Specifications of Commercially Available Botulinum Toxin Products*

Newsletter - January 2007
Data for β0ToxinA®, Neoβ0ToxinA®, and β0ToxinA® Instant derived from research and trials conducted by International Cosmetic Research on behalf of Pharmastock LTD (

Leggi tutto...


SeaLab Europe LLP - Suite 36, 88-90 Hatton Garden, Holborn, EC1N 8PN, Londra (Regno Unito)

Telefono: +44 7077073252

Fax: +44 7077077606


Per ricevere la nostra newsletter registrati al nostro esclusivo "botoxina Foundation members Club" inserendo la tua email:

sottomarino newsletter

Potrai aggiudicarti un tour sul nostro battiscafo marino e nel nostro laboratorio.